by Sam Collins | February 26, 2010 1:44 am
iShares Nasdaq Biotechnology Index Fund (IBB[1]) – The goal of this exchange-traded fund (ETF) is to provide investment results that correspond generally to the price-and-yield performance of the Nasdaq Biotechnology Index (NBI[2]).
In short, biotech stocks have broken out from a type of triple-top on a broad accumulation.
This breakout represents a 17-month high with an eventual target of $95 to $100.
The stochastic and other internal indicators are overbought, and investors may want to wait to buy IBB on a pullback to $85, but the course is clear, and that is definitely up.
Related Articles:
FREE Stock Picks Every Week!
Get the hottest stocks to buy and sell delivered right to your e-mail inbox every week! Start now.[6]
Source URL: http://www.investorplace.com/2010/02/stock-picks-ishares-nasdaq-biotechnology-index-fund-ibb/
Short URL: http://www.investorplace.com/?p=6014
Copyright ©2012 InvestorPlace Media, LLC. All rights reserved. 700 Indian Springs Drive, Lancaster, PA 17601.